Acumen Pharmaceuticals Stock (NASDAQ: ABOS) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 406.44K |
Day Range | - - - |
52 Wk Range | 1.81 - 7.98 |
Market Cap | $176.03M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 57 |
Short Interest | 2.21% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Acumen Pharmaceuticals (NASDAQ:ABOS) through any online brokerage.
Other companies in Acumen Pharmaceuticals’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Outlook Therapeutics (NASDAQ:OTLK), Innate Pharma (NASDAQ:IPHA), Skye Bioscience (NASDAQ:SKYE) and Galectin Therapeutics (NASDAQ:GALT).
There is no analysis for Acumen Pharmaceuticals.
Acumen Pharmaceuticals has a consensus price target of $17.38.
The stock price for Acumen Pharmaceuticals (NASDAQ: ABOS) is $2.93 last updated July 19, 2024 at 4:55 PM EDT.
There are no upcoming dividends for Acumen Pharmaceuticals.
Acumen Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Acumen Pharmaceuticals.
Acumen Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.